{"id":154,"date":"2022-06-21T15:36:20","date_gmt":"2022-06-21T06:36:20","guid":{"rendered":"https:\/\/cdgw3.naist.jp\/en\/?p=154"},"modified":"2023-06-21T15:10:30","modified_gmt":"2023-06-21T06:10:30","slug":"development-of-technology-for-high-expression-of-heterologous-proteins-in-plants-application-to-plant-derived-covid-19-vaccine-2022-6-20","status":"publish","type":"post","link":"https:\/\/cdgw3.naist.jp\/en\/154\/","title":{"rendered":"Development of Technology for High Expression of Heterologous Proteins in Plants &#8211; Application to Plant-derived COVID-19 Vaccine &#8211; (2022.6.20)"},"content":{"rendered":"\n<p><strong>Summary<\/strong><\/p>\n\n\n\n<p>\u3000Professor Ko Kato (CDG) and his group at NAIST (President: Dr. Kazuhiro Shiozaki) has developed the translation enhancer that enhances the expression of heterologous proteins in plants.<\/p>\n\n\n\n<p>\u3000NAIST has assigned the rights to Medicago Inc. for the production of a plant-derived COVID-19 vaccine for the prevention of novel coronavirus infection (COVID-19), and the results are being used by Medicago Inc. to improve production efficiency.<\/p>\n\n\n\n<p><strong>For more information, click here<\/strong>.<\/p>\n\n\n\n<p>Development of Technology for High Expression of Heterologous Proteins in Plants &#8211; Application to Plant-derived COVID-19 Vaccine<\/p>\n\n\n\n<figure class=\"wp-block-image size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/cdgw3.naist.jp\/en\/wp-content\/uploads\/2023\/05\/CDG_logo1-1024x768.png\" alt=\"\" class=\"wp-image-15\" width=\"512\" height=\"384\" srcset=\"https:\/\/cdgw3.naist.jp\/en\/wp-content\/uploads\/2023\/05\/CDG_logo1-1024x768.png 1024w, https:\/\/cdgw3.naist.jp\/en\/wp-content\/uploads\/2023\/05\/CDG_logo1-300x225.png 300w, https:\/\/cdgw3.naist.jp\/en\/wp-content\/uploads\/2023\/05\/CDG_logo1-768x576.png 768w, https:\/\/cdgw3.naist.jp\/en\/wp-content\/uploads\/2023\/05\/CDG_logo1.png 1200w\" sizes=\"auto, (max-width: 512px) 100vw, 512px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Summary \u3000Professor Ko Kato (CDG) and his group at NAIST (President: Dr. Kazuhiro Shiozaki) has developed the t [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,6,5],"tags":[],"class_list":["post-154","post","type-post","status-publish","format-standard","hentry","category-results","category-news","category-action"],"_links":{"self":[{"href":"https:\/\/cdgw3.naist.jp\/en\/wp-json\/wp\/v2\/posts\/154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdgw3.naist.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdgw3.naist.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdgw3.naist.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cdgw3.naist.jp\/en\/wp-json\/wp\/v2\/comments?post=154"}],"version-history":[{"count":3,"href":"https:\/\/cdgw3.naist.jp\/en\/wp-json\/wp\/v2\/posts\/154\/revisions"}],"predecessor-version":[{"id":236,"href":"https:\/\/cdgw3.naist.jp\/en\/wp-json\/wp\/v2\/posts\/154\/revisions\/236"}],"wp:attachment":[{"href":"https:\/\/cdgw3.naist.jp\/en\/wp-json\/wp\/v2\/media?parent=154"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdgw3.naist.jp\/en\/wp-json\/wp\/v2\/categories?post=154"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdgw3.naist.jp\/en\/wp-json\/wp\/v2\/tags?post=154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}